Skip to content

Envoy Medical COCH Net Operating Loss Carryforwards

Net Operating Loss Carryforwards at other companies

CorMedix logo
CorMedixCRMD
$91.5-100.0%
Alignment Healthcare logo
Alignment HealthcareALHC
$95.33M-74.5%
Unusual Machines logo
Unusual MachinesUMAC
$23.5M+147%
Princeton Bancorp, Inc. logo
Princeton Bancorp, Inc.BPRN
$13.1M-7.7%
The RealReal logo
The RealRealREAL
$3.25M+18.6%
PJT Partners logo
PJT PartnersPJT
$53.2M

Other financials

Income statement

See full
Revenue$39.0K-15.2%
Gross profit-$274.0K-52.2%
Operating income-$6.0M-16.7%
Net income-$4.4M+12.9%
EPS (diluted)-$0.08+72.4%

Balance sheet

See full
Cash & equivalents$25.3M+376%
Total debt$919.0K-2.8%
Total equity$10.2M+142%
Total assets$29.8M+187%

Cash flow

See full
Operating cash flow-$6.1M-62.7%
CapEx$172.0K
Free cash flow-$5.9M-28.5%

Valuation

See full
Market cap$61M+83.5%
P/S260.7×+111×

Profitability

See full
Gross margin-310.7%+31.6pp
Operating margin-9,881.2%+805pp
Net margin-9,875.6%+771pp
FCF margin-7,626.6%-652pp

Returns & leverage

See full
Return on equity328.7%
Debt / equity0.1×
Current ratio2.3×+1.2×

Where this comes from

Reported directly by Envoy Medical in its filing.

Tagged under the XBRL concept us-gaap:DeferredTaxAssetsTaxCreditCarryforwards.

The official record: Envoy Medical’s 10-K, filed March 23, 2026, on SEC EDGAR. View the filing →

Ask your AI about Envoy Medical's net operating loss carryforwards.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Envoy Medical's net operating loss carryforwards?
Envoy Medical (COCH) reported net operating loss carryforwards of $1.7M in Q4 2025.
What is the long-term trend for Envoy Medical's net operating loss carryforwards?
Over 2 years (2023 to 2025), Envoy Medical's net operating loss carryforwards has grown at a -6.8% compound annual growth rate (CAGR), from $1.96M to $1.7M.
What does net operating loss carryforwards mean?
These are tax assets representing losses that can be used to reduce taxable income in future periods. They provide a potential future tax shield, improving cash flow by lowering future tax payments. Investors monitor these to estimate the duration and magnitude of potential tax savings.